Core Insights - Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing drugs for neurodegenerative disorders, specifically targeting dementia with Lewy bodies (DLB) and Alzheimer's disease [1][4] - The company has launched a new podcast episode during DLB Awareness Month, discussing the clinical research and unique symptoms associated with DLB [1][2] Company Overview - Cognition Therapeutics is engaged in discovering and developing small molecule therapeutics aimed at age-related degenerative disorders of the central nervous system and retina [4] - The lead candidate, CT1812, is currently being investigated in clinical programs for Alzheimer's disease, DLB, and dry age-related macular degeneration [4] SHIMMER Study Details - The SHIMMER study is a Phase 2 clinical trial involving 130 adults with mild-to-moderate DLB, assessing the efficacy of CT1812 [5][6] - Participants are randomized to receive either a placebo or one of two doses of CT1812 (100 mg or 300 mg) for six months, with various cognitive assessments conducted throughout the study [5] - The study is supported by a grant from the National Institute on Aging totaling approximately $30 million and is being conducted at over 30 sites in the U.S. [6]

SAN FRANCISCO, Oct. 10, 2024 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment, will release financial results for the fourth quarter (Q4) and full year of fiscal 2024 after the close of regular trading on Tuesday, November 19, 2024. Members of Dolby management will lead a conference call open to all interested parties to discuss Q4 and full year fiscal 2024 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Tuesday, November 19, 2024. Access t ...

Dolby Laboratories, Inc. (DLB) has launched a new suite of cloud video products and solutions designed for real-time interactive streaming. Available as standalone tools or integrated solutions, they offer superior live sports and entertainment experiences. This launch follows Dolby's recent acquisition of THEO Technologies, a leading provider of premium video streaming tools used by prominent sports, media and entertainment companies globally. THEOads is an advanced ad insertion tool that enhances advertis ...

Core Viewpoint - Dolby Laboratories reported a mixed performance in its latest earnings, with non-GAAP EPS exceeding estimates while revenues declined year-over-year, prompting a cautious outlook for the remainder of the fiscal year [2][3][10]. Financial Performance - Dolby's Q3 fiscal 2024 non-GAAP EPS was 71 cents, up from 55 cents in the prior-year quarter, surpassing the Zacks Consensus Estimate by 20.3% [2] - Revenues for the quarter were $288.8 million, a decline of 3% year-over-year, but still beating the Zacks Consensus Estimate by 0.9% [2] - Gross profit decreased to $253.1 million from $256.8 million in the year-ago quarter, while total operating expenses fell to $216.3 million from $240.9 million [6] Segment Performance - Licensing revenues were $267 million, down 2% year-over-year, while Products and Services revenues fell 14% to $21.7 million due to weak box office trends and device sales [4] - Broadcast Licensing contributed 36% to total licensing revenues, with Mobile Licensing, Consumer Electronics, PC Licensing, and Other Markets accounting for 11%, 10%, 15%, and 19% respectively [5] Cash Flow and Share Repurchase - For the six months ending June 30, Dolby generated $211.1 million in net cash from operating activities, down from $282.1 million in the prior-year period [7] - The company repurchased nearly 423,000 shares during the quarter, with $72 million remaining in its stock repurchase authorization, and an increase of $350 million to its stock repurchase program was approved [8] Outlook - For Q4 fiscal 2024, Dolby expects GAAP EPS between 31-46 cents and non-GAAP EPS between 61-76 cents, with revenues projected at $300-$320 million [9] - Full-year revenue estimates have been revised down to $1.27-$1.29 billion from a previous estimate of $1.3 billion due to lower-than-anticipated shipments and cinema revenues [10] - Dolby anticipates GAAP operating margin at 20% and non-GAAP operating margin at nearly 31% for the fiscal year [11] Estimate Trends - Recent estimates have shown a downward trend, with the consensus estimate shifting down by 21.39% [12] - Dolby Laboratories currently holds a Zacks Rank 3 (Hold), indicating expectations for an in-line return in the coming months [14]

Company Announcement - Dolby Laboratories, Inc. will have a fireside chat hosted by President and CEO Kevin Yeaman at the Goldman Sachs Communacopia and Technology Conference on September 12, 2024, at 8:50 AM PT [1] - A live webcast and replay of the event will be accessible at http://investor.dolby.com [1] Company Overview - Dolby Laboratories is headquartered in San Francisco, California, with a global presence [2] - The company specializes in transforming sight and sound into exceptional experiences for billions, partnering with various stakeholders in entertainment and communications [2] - Key technologies include Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby.io [2]

SAN FRANCISCO, Aug. 13, 2024 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced that Robert Park, Chief Financial Officer, will host a fireside chat at the Rosenblatt Technology Summit virtually on Tuesday, August 20, 2024, at 3:00 PM ET. A live webcast and replay of the event will be available at http://investor.dolby.com. About Dolby Laboratories Dolby Laboratories (NYSE: DLB) is based in San Francisco, California with offices around the globe. From movies and TV shows, to apps, music, sp ...

Core Viewpoint - Dolby Laboratories reported a third-quarter fiscal 2024 non-GAAP EPS of 71 cents, up from 55 cents in the prior-year quarter, exceeding the Zacks Consensus Estimate by 20.3% due to lower operating costs and higher operating income [1] Financial Performance - Revenues for the quarter decreased by 3% year over year to $288.8 million, slightly beating the Zacks Consensus Estimate by 0.9% [1] - Licensing revenues were $267 million, down 2% year over year, while Products and Services revenues fell 14% to $21.7 million, attributed to weak box office trends and device sales [3] - Gross profit was $253.1 million compared to $256.8 million in the year-ago quarter, with total operating expenses decreasing to $216.3 million from $240.9 million [5] Segmental Performance - Broadcast Licensing contributed 36% to total licensing revenues, while Mobile Licensing, Consumer Electronics, PC Licensing, and Other Markets accounted for 11%, 10%, 15%, and 19% respectively [4] - Management anticipates continued downward trends across Mobile, Consumer Electronics, and Broadcasting for the full year [4] Cash Flow and Liquidity - For the six months ending June 30, Dolby generated $211.1 million in net cash from operating activities, down from $282.1 million in the prior-year period [6] - As of June 30, 2024, the company had $741.6 million in cash and cash equivalents, with total liabilities of $526.2 million [6] Shareholder Returns - The company announced a cash dividend of 30 cents per share for Class A and Class B common stock, payable on August 27, 2024 [7] - Dolby repurchased nearly 423,000 shares during the quarter, with $72 million remaining in its stock repurchase authorization, and an increase of $350 million to its stock repurchase program was approved [8] Outlook - For the fourth quarter of fiscal 2024, Dolby expects GAAP EPS between 31-46 cents and non-GAAP EPS between 61-76 cents, with revenues projected at $300-$320 million [9] - Full-year revenue estimates have been revised to a range of $1.27-$1.29 billion, down from the previous estimate of $1.3 billion due to lower-than-anticipated shipments and cinema revenues [10] - The company projects GAAP operating margin at 20% and non-GAAP operating margin at nearly 31% [11]

Core Insights - For the quarter ended June 2024, Dolby Laboratories reported revenue of $288.82 million, a decrease of 3.2% year-over-year, with an EPS of $0.71 compared to $0.55 in the same quarter last year, exceeding the Zacks Consensus Estimate of $286.26 million by 0.89% and delivering an EPS surprise of 20.34% [1] Revenue Performance - Revenue from Products and Services was $21.74 million, falling short of the average estimate of $26 million by three analysts, representing a year-over-year decline of 14% [3] - Revenue from Licensing was $267.08 million, surpassing the estimated $260.26 million by three analysts, but reflecting a decrease of 2.2% compared to the previous year [4] Gross Margin Analysis - Gross Margin for Licensing was reported at $249.70 million, exceeding the average estimate of $245.63 million from three analysts [5] - Gross Margin for Products and Services was $3.46 million, also above the average estimate of $2.86 million from three analysts [6] Stock Performance - Shares of Dolby Laboratories have returned -6.7% over the past month, compared to a -5.9% change in the Zacks S&P 500 composite, with the stock currently holding a Zacks Rank 4 (Sell), indicating potential underperformance in the near term [6]

Dolby Laboratories, Inc. (NYSE:DLB) Q3 2024 Results Conference Call August 7, 2024 5:00 PM ET Company Participants Peter Goldmacher - VP, IR Kevin Yeaman - CEO Robert Park - CFO Conference Call Participants Ralph Schackart - William Blair Jim Goss - Barrington Research Operator Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing Fiscal Third Quarter Results. During the presentation, all participants will be in a listen only mode [Operator Instruction ...

Dolby Laboratories (DLB) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.55 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 20.34%. A quarter ago, it was expected that this creator and licensor of audio, video and voice technologies would post earnings of $1.17 per share when it actually produced earnings of $1.27, delivering a surpr ...